相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression
Pauline Ferraris et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
Interferon lambda 4 expression is suppressed by the host during viral infection
MeeAe Hong et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Host - hepatitis C viral interactions: The role of genetics
Markus H. Heim et al.
JOURNAL OF HEPATOLOGY (2016)
Breadth of the HCV-specific CD4+T-cell response in spontaneous resolvers is independent of the IL-28 haplotype
C. Scheurich et al.
JOURNAL OF VIRAL HEPATITIS (2016)
IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis C
Benjamin Kraemer et al.
PLOS ONE (2016)
Prolonged activation of innate antiviral gene signature after childbirth is determined by IFNL3 genotype
Aryn A. Price et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Influence of IFNL3 and HLA-DPB1 genotype on postpartum control of hepatitis C virus replication and T-cell recovery
Jonathan R. Honegger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
IFN-λ3 polymorphism indirectly influences NK cell phenotype and function during acute HCV infection
Marion Depla et al.
IMMUNITY INFLAMMATION AND DISEASE (2016)
Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: A long-term cohort study
Savino Bruno et al.
ANTIVIRAL RESEARCH (2015)
A Polymorphism in Interferon L3 Is an Independent Risk Factor for Development of Hepatocellular Carcinoma After Treatment of Hepatitis C Virus Infection
Kuo-Chin Chang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance
Thomas R. O'Brien et al.
JOURNAL OF HEPATOLOGY (2015)
EASL Recommendations on Treatment of Hepatitis C 2015
JOURNAL OF HEPATOLOGY (2015)
Hepatitis C Virus Reinfection and Spontaneous Clearance of Reinfection-the InC3 Study
Rachel Sacks-Davis et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Expression of Interferon Lambda 4 Is Associated with Reduced Proliferation and Increased Cell Death in Human Hepatic Cells
Olusegun O. Onabajo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
IFN-λ is able to augment TLR-mediated activation and subsequent function of primary human B cells
Rik A. de Groen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Altered effector functions of NK cells in chronic hepatitis C are associated with IFNL3 polymorphism
Magdalena Rogalska-Taranta et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Roles of unphosphorylated ISGF3 in HCV infection and interferon responsiveness
Pil Soo Sung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
NK cells require IL-28R for optimal in vivo activity
Fernando Souza-Fonseca-Guimaraes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease
Mohammed Eslam et al.
NATURE COMMUNICATIONS (2015)
New era for management of chronic hepatitis C virus using direct antiviral agents: A review
Tamer Elbaz et al.
JOURNAL OF ADVANCED RESEARCH (2015)
IFN-λ-mediated IL-12 production in macrophages induces IFN-γ production in human NK cells
Rik A. de Groen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection
Karen Fitzmaurice et al.
GUT (2015)
IFNL4 and IFNL3 Associated Polymorphisms Strongly Influence the Spontaneous IFN-Alpha Receptor-1 Expression in HCV-Infected Patients
Licia Bordi et al.
PLOS ONE (2015)
Interferon Lambda Alleles Predict Innate Antiviral Immune Responses and Hepatitis C Virus Permissiveness
Timothy Sheahan et al.
CELL HOST & MICROBE (2014)
Clearance of Hepatitis C Infection Is Associated With the Early Appearance of Broad Neutralizing Antibody Responses
William O. Osburn et al.
HEPATOLOGY (2014)
IFNL cytokines do not modulate human or murine NK cell functions
Maria H. Morrison et al.
HUMAN IMMUNOLOGY (2014)
IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis
Kate S. O'Connor et al.
INNATE IMMUNITY (2014)
Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus
Peter V. Aka et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Lymphocytes Degranulation in Liver in Hepatitis C Virus Carriers Is Associated With IFNL4 Polymorphisms and ALT Levels
Evelyne Jouvin-Marche et al.
JOURNAL OF INFECTIOUS DISEASES (2014)
Lambda Interferon Serum Levels in Patients with Chronic Hepatitis C Virus Infection According to Their Response to Therapy with Pegylated Interferon and Ribavirin
Claudio Torres et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
IFN-λ4: The Paradoxical New Member of the Interferon Lambda Family
Thomas R. O'Brien et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Ewa Terczynska-Dyla et al.
NATURE COMMUNICATIONS (2014)
IL-28B is a Key Regulator of B- and T-Cell Vaccine Responses against Influenza
Adrian Egli et al.
PLOS PATHOGENS (2014)
Subgroup Differences in Response to 8 Weeks of Ledipasvir/Sofosbuvir for Chronic Hepatitis C
Thomas R. O'Brien et al.
OPEN FORUM INFECTIOUS DISEASES (2014)
Genome-Wide Association Study of Spontaneous Resolution of Hepatitis C Virus Infection: Data From Multiple Cohorts
Priya Duggal et al.
ANNALS OF INTERNAL MEDICINE (2013)
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses
Ole J. Hamming et al.
EMBO JOURNAL (2013)
Association of IL28B Genotype With Fibrosis Progression and Clinical Outcomes in Patients With Chronic Hepatitis C: A Longitudinal Analysis
Mazen Noureddin et al.
HEPATOLOGY (2013)
IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction
Stephanie Bibert et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes
Y. Wang et al.
JOURNAL OF VIRAL HEPATITIS (2013)
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
Ludmila Prokunina-Olsson et al.
NATURE GENETICS (2013)
Rapid and sustained autologous neutralizing response leading to early spontaneous recovery after HCV infection
Laura Esteban-Riesco et al.
VIROLOGY (2013)
Hepatitis C Virus Pathogen Associated Molecular Pattern (PAMP) Triggers Production of Lambda-Interferons by Human Plasmacytoid Dendritic Cells
Amy E. L. Stone et al.
PLOS PATHOGENS (2013)
Mechanisms of T cell tolerance towards the allogeneic fetus
Adrian Erlebacher
NATURE REVIEWS IMMUNOLOGY (2013)
Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir
Fred Poordad et al.
GASTROENTEROLOGY (2012)
HCV Infection Induces a Unique Hepatic Innate Immune Response Associated With Robust Production of Type III Interferons
Emmanuel Thomas et al.
GASTROENTEROLOGY (2012)
IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes
Pierre-Yves Bochud et al.
HEPATOLOGY (2012)
IL-29 Is the Dominant Type III Interferon Produced by Hepatocytes During Acute Hepatitis C Virus Infection
Heiyoung Park et al.
HEPATOLOGY (2012)
Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
Satoru Joshita et al.
HUMAN IMMUNOLOGY (2012)
The interferons and their receptors-distribution and regulation
Nicole A. de Weerd et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Type III IFNs Are Produced by and Stimulate Human Plasmacytoid Dendritic Cells
Zhiwei Yin et al.
JOURNAL OF IMMUNOLOGY (2012)
Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion
Sukanya Raghuraman et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
IL28B genetic variation and hepatitis C virus-specific CD4+ T-cell responses in anti-HCV-positive blood donors
M. Bes et al.
JOURNAL OF VIRAL HEPATITIS (2012)
Type III Interferons, IL-28 and IL-29, Are Increased in Chronic HCV Infection and Induce Myeloid Dendritic Cell-Mediated FoxP3+Regulatory T Cells
Angela Dolganiuc et al.
PLOS ONE (2012)
IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression
Bi-Sheng Liu et al.
BLOOD (2011)
A View to Natural Killer Cells in Hepatitis C
Naglaa H. Shoukry et al.
GASTROENTEROLOGY (2011)
Hepatitis C Virus Induces Interferon-λ and Interferon-Stimulated Genes in Primary Liver Cultures
Svetlana Marukian et al.
HEPATOLOGY (2011)
Natural Killer Inhibitory Receptor Expression Associated with Treatment Failure and Interleukin-28B Genotype in Patients with Chronic Hepatitis C
Lucy Golden-Mason et al.
HEPATOLOGY (2011)
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC
Carlo Fabris et al.
JOURNAL OF HEPATOLOGY (2011)
Interferon-lambda serum levels in hepatitis C
Bettina Langhans et al.
JOURNAL OF HEPATOLOGY (2011)
Reply to Kramer et al.: Human natural killer (NK) cell inhibition by IL28A
Clair M. Gardiner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Do λ-IFNs IL28A and IL28B act on human natural killer cells?
Benjamin Kraemer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection
Megan M. Dring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study
Vijayaprakash Suppiah et al.
PLOS MEDICINE (2011)
IL-28A, IL-28B, and IL-29: Promising cytokines with type I interferon-like properties
Katrin Witte et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin
Mark G. Swain et al.
GASTROENTEROLOGY (2010)
A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice
Hans L. Tillmann et al.
GASTROENTEROLOGY (2010)
Hepatic ISG Expression Is Associated With Genetic Variation in Interleukin 28B and the Outcome of IFN Therapy for Chronic Hepatitis C
Masao Honda et al.
GASTROENTEROLOGY (2010)
Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
Andri Rauch et al.
GASTROENTEROLOGY (2010)
Spontaneous Control of Primary Hepatitis C Virus Infection and Immunity Against Persistent Reinfection
William O. Osburn et al.
GASTROENTEROLOGY (2010)
IL28B Genotype Is Associated With Differential Expression of Intrahepatic Interferon-Stimulated Genes in Patients With Chronic Hepatitis C
Thomas J. Urban et al.
HEPATOLOGY (2010)
IFN-λ1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells
Jihong Dai et al.
BLOOD (2009)
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines
K. Witte et al.
GENES AND IMMUNITY (2009)
Treatment Options for Hepatitis C and the Rationale for Low Response Rates in African Americans
Cheu Manka et al.
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Vijayaprakash Suppiah et al.
NATURE GENETICS (2009)
Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
Yasuhito Tanaka et al.
NATURE GENETICS (2009)
Host genetic determinants of spontaneous hepatitis C clearance
Andri Rauch et al.
PHARMACOGENOMICS (2009)
Interferon-λ1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro
Shekar Srinivas et al.
IMMUNOLOGY (2008)
Interferon signaling and treatment outcome in chronic hepatitis C
Magdalena Sarasin-Filipowicz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C
T. Asselah et al.
GUT (2008)
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment response
Jordan J. Feld et al.
HEPATOLOGY (2007)
Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
Manuela F. Meyer et al.
VIROLOGY JOURNAL (2007)
Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C
Jan M. Pestka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda 1/IL-29)
W. J. Jordan et al.
GENES AND IMMUNITY (2007)
Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes
Sean E. Doyle et al.
HEPATOLOGY (2006)
Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection
LM Chen et al.
GASTROENTEROLOGY (2005)
Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C -: A randomized study of treatment duration and ribavirin dose
SJ Hadziyannis et al.
ANNALS OF INTERNAL MEDICINE (2004)
Regulatory T cells mediate maternal tolerance to the fetus
VR Aluvihare et al.
NATURE IMMUNOLOGY (2004)
HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection
SI Khakoo et al.
SCIENCE (2004)
Neutralizing antibody response during acute and chronic hepatitis C virus infection
C Logvinoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort
JJ Post et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Genomic analysis of the host response to hepatitis C virus infection
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease
R Thimme et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Course and outcome of hepatitis C
JH Hoofnagle
HEPATOLOGY (2002)
DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection
CB Bigger et al.
JOURNAL OF VIROLOGY (2001)
Hepatitis C virus load during pregnancy and puerperium
HH Lin et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C
A Gervais et al.
JOURNAL OF HEPATOLOGY (2000)